#9 Newsletter – JP Jenkins
Ninth Edition This month we announced another new client Bowleven plc, with 2 more to go live very shortly. We have a number of new clients announce this month to go live in November. We highly anticipate the budget, to see what will happen and how this will affect the investment landscape in both public […]
#8 Newsletter – JP Jenkins
Eighth Edition This month we announced another 3 new client’s, with 2 more to go live very shortly. Sondrel, BiVictriX Therapeutics plc & 350 PPM LTD all went live over the last month! Congratulations all. We now have Bowleven plc to go live next Tuesday and another to go live the week after. First and […]
#7 Newsletter – JP Jenkins
Seventh Edition This month we announced another new client – Destiny Pharma plc and we also have Sondrel going live this Thursday! We have Bowleven plc and BiVictriX Therapeutics plc going live in September. We are delighted to announce the following new admissions to JP Jenkins: Destiny Pharma plc (JPJ:DEST), announced it’s shares have been […]
#6 Newsletter – JP Jenkins
Sixth Edition No Summer Holidays Here. This month we announced another new client – Superdry (Well done to all the team), alongside this we saw the announcements from Sondrel, i(x) Net Zero and Destiny Pharma Limited who intend to join JPJ very soon. We are delighted to announce the following new admissions to JP Jenkins: […]
#5 Newsletter – JP Jenkins
Fifth Edition This month we announced another new client (Lexington Gold Warrants), saw the announcement of Superdry PLC joining JPJ and lots of celebratory drinks / awards. Hoorah! We are delighted to announce the following new admissions to JP Jenkins: Lexington Gold (JPJ: LEXW): LEX announces its Warrants (https://lnkd.in/dCnT99cx) have been admitted to trade on […]
#4 Newsletter – JP Jenkins
Fourth Edition This month we announced four new clients, saw trading volumes tick up and more brokers connect. Hoorah! We are delighted to announce the following new admissions to JP Jenkins: Molecular Energies (JPJ:MEN): Molecular Energies has four primary business divisions – an innovation arm focussing on the development of sustainable aviation fuel and other […]
Iress Partners with InfinitX, JP Jenkins for Unlisted Security Trading
Iress today announces that it has partnered with InfinitX to enable its clients to trade unlisted securities through Iress’s EMS Trader and IOS+ platforms. This fully electronic integration with JP Jenkins, the liquidity venue for unlisted assets, enables private companies to allow trading in their shares on a matched bargain basis. Any client using Iress’s […]
3# Newsletter
April 18, 2024 3# Newsletter April 2024 Since going live on the 5th March 2024 for electronic trading and a shift to digital-first operations, we have significantly modernised our venue for trading unquoted securities. Our team is proving the thesis that seamless electronic connection brings more liquidity and greater transparency. We’re encouraged to see JP […]
#2 Newsletter – JP Jenkins
Second Edition This month we announced a major shift towards digital-first operations, significantly modernising our venue for trading unquoted securities. This transformation was marked by the full digital integration of many UK brokers into its system. This move towards automation aims to enhance liquidity, transparency, and scalability, accommodating a growing number of issuers and traded […]
JP Jenkins Monthly Newsletter #2
JP Jenkins March 20, 2024 Second Edition This month we announced a major shift towards digital-first operations, significantly modernising our venue for trading unquoted securities. This transformation was marked by the full digital integration of many UK brokers into its system. This move towards automation aims to enhance liquidity, transparency, and scalability, accommodating a growing […]
